Sermorelin 5 mg research-grade lyophilized peptide powder in a glass vial. Sermorelin is the amidated 1–29 N-terminal fragment of human GHRH (GHRH(1–29)NH2) studied in experimental models of GH/IGF-1 axis regulation, pituitary somatotroph function, hypothalamic GHRH receptor signaling and broader endocrine physiology.
Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Purity
99%+ (HPLC, third-party tested)
Form
Lyophilized peptide powder
Content
5 mg Sermorelin per vial
Packaging
Glass vial with sterile closure
Storage
Store lyophilized at 2–8 °C in a dry, desiccated place, protected from light.
Molecular formula
C149H246N44O42S
Molecular weight
≈ 3357.9 g·mol⁻¹
Sequence
H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-NH2 (GHRH(1–29)NH2)
CAS number
86168-78-7 (acetate)
In laboratory workflows, lyophilized research peptides are typically handled with suitable sterile diluents such as bacteriostatic water (BAC). For a compatible research-only solvent, see
Bacteriostatic water – 10 ml .
Research Overview
Sermorelin (GHRH(1–29)NH2) is a truncated, bioactive region of human growth hormone–releasing hormone used as a tool compound to probe pituitary somatotroph activation, GH pulse dynamics, IGF-1 modulation and hypothalamic–pituitary signaling in vitro and in vivo laboratory models.
Primary Research Areas
-
GH/IGF-1 axis modulation: Experimental evaluation of GHRH receptor activation and downstream endocrine signaling.
-
Pituitary somatotroph function: Studies of GH secretion dynamics, receptor coupling and feedback regulation.
-
Hypothalamic–pituitary neuroendocrinology: Circuit-level analyses of GHRH interactions with somatostatin and related peptides.
-
Peptide chemistry & stability: Structure–activity relationships for GHRH(1–29) analogs and amidation effects.
